Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase

被引:0
|
作者
Klöss, S [1 ]
Bouloumié, A [1 ]
Mülsch, A [1 ]
机构
[1] Univ Frankfurt Klinikum, Inst Kardiovask Physiol, D-60590 Frankfurt, Germany
关键词
aging; hypertension; genetic; guanylyl cyclase; aorta; nitric oxide;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We analyzed the influence of aging and genetic hypertension on the function and expression of soluble guanylyl cyclase (sGC) in the aortas of prehypertensive and old spontaneously hypertensive rats (SHR) as well as in age-matched normotensive Wistar-Kyoto rats (WKY). The expression of heterodimeric sGC (alpha(1) and beta(1)) was assessed at the mRNA and protein level, and its function was assessed by the relaxant responses of phenylephrine-contracted endothelium-denuded aortic rings to the nitric oxide (NO) donor sodium nitroprusside. The vasodilator potency of sodium nitroprusside was significantly reduced (P<0.05) with age (3- to 6-fold increase in the EC50 in old WKY and SHR compared with their young counterparts) as well as with hypertension (3-fold increase in old SHR compared with age-matched WKY), whereas the vasodilator potency of sodium nitroprusside did not differ between young SHR and WKY. A similar influence of aging and hypertension on NO-stimulated GC activity was revealed at the GC expression level: Whereas the beta(1) protein content was similar in young rats of both strains, old WKY exhibited 60% lower and old SHR exhibited 80% lower beta(1) subunit protein compared with young rats (P<0.05), Moreover, the abundance of alpha(1) and beta(1) mRNA (assessed by reverse transcriptase-polymerase chain reaction) was similar in young rats but was 2.5-fold (alpha(1)) and 4.3-fold (beta(1)) lower in old SHR compared with old WKY. In conclusion, our findings show that both aging and hypertension decrease sGC expression and its NO-dependent activation in aortic tissue. Downregulation of sGC may therefore contribute to arterial dysfunction in senescence and chronic hypertension.
引用
收藏
页码:43 / 47
页数:5
相关论文
共 50 条
  • [21] Soluble guanylyl cyclase as a therapeutic target in chronic obstructive pulmonary disease (COPD)
    Constantinos Glynos
    Dimitris Toumpanakis
    Zongmin Zhou
    Peter Brouckaert
    Theodoros Vassilakopoulos
    Andreas Papapetropoulos
    BMC Pharmacology and Toxicology, 14 (Suppl 1)
  • [22] Effect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclase
    Oppermann, M.
    Dao, V. T-V
    Suvorava, T.
    Bas, M.
    Kojda, G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 155 (03) : 335 - 342
  • [23] Cyclic GMP-dependent protein kinase and soluble guanylyl cyclase disappear in elicited rat neutrophils
    Ciuman, Malgorzata
    Siednienko, Jakub
    Czyzyk, Rafal
    Witwicka, Hanna
    Kolosionek, Ewa
    Kobialka, Marcin
    Gorczyca, Wojciech A.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2006, 1760 (11): : 1618 - 1623
  • [24] Restoring Soluble Guanylyl Cyclase Expression and Function Blocks the Aggressive Course of Glioma
    Zhu, Haifeng
    Li, Jessica Tao
    Zheng, Fang
    Martin, Emil
    Kots, Alexander Y.
    Krumenacker, Joshua S.
    Choi, Byung-Kwon
    McCutcheon, Ian E.
    Weisbrodt, Norman
    Boegler, Oliver
    Murad, Ferid
    Bian, Ka
    MOLECULAR PHARMACOLOGY, 2011, 80 (06) : 1076 - 1084
  • [25] Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model
    Crassous, Pierre-Antoine
    Couloubaly, Samba
    Huang, Can
    Zhou, Zongmin
    Baskaran, Padmamalini
    Kim, David D.
    Papapetropoulos, Andreas
    Fioramonti, Xavier
    Duran, Walter N.
    Beuve, Annie
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 303 (05): : H597 - H604
  • [26] Doxazosin and soluble guanylate cyclase in a rat model of hypertension
    Rodríguez-Feo, JA
    Gómez, J
    Núñez, A
    Rico, L
    Fortes, J
    de Andrés, R
    Cabestrero, F
    Farré, J
    Casado, S
    López-Farré, A
    REVISTA ESPANOLA DE CARDIOLOGIA, 2001, 54 (07): : 880 - 886
  • [27] Attenuation of nitric oxide-stimulated soluble guanylyl cyclase from the rat brain by halogenated volatile anesthetics
    Masaki E.
    Kondo I.
    Journal of Anesthesia, 1998, 12 (2) : 81 - 86
  • [28] Halogenated volatile anesthetics inhibit carbon monoxide-stimulated soluble guanylyl cyclase activity in rat brain
    Masaki, E
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2000, 44 (03) : 321 - 325
  • [29] Soluble Guanylyl Cyclase Activator BI 685509 Reduces Portal Hypertension and Portosystemic Shunting in a Rat Thioacetamide-Induced Cirrhosis Model
    Jones, Amanda K.
    Chen, Hongxing
    Ng, Khing Jow
    Villalona, Jorge
    McHugh, Mark
    Zeveleva, Svetlana
    Wilks, James
    Brilisauer, Klaus
    Bretschneider, Tom
    Qian, Hu Sheng
    Fryer, Ryan M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 386 (01) : 70 - 79
  • [30] Co-operation between particulate and soluble guanylyl cyclase systems in the rat renal glomeruli
    Stepinski, J
    Wendt, U
    Lewko, B
    Angielski, S
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2000, 51 (03): : 497 - 512